Nuciferine activates intestinal TAS2R46 to attenuate metabolic disorders and hyperlipidemia via hepatic VLDL regulation DOI
Ding Chen,

Jian Ruan,

Jingxian Huang

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156800 - 156800

Published: April 1, 2025

Language: Английский

From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders DOI Creative Commons
Yuqi He,

Yumeng Lin,

Jinfeng Song

et al.

Cell Communication and Signaling, Journal Year: 2025, Volume and Issue: 23(1)

Published: March 7, 2025

In recent 10 years, ferroptosis has become a hot research direction in the scientific community as new way of cell death. Iron toxicity accumulation and lipotoxicity are unique features. Several studies have found that is involved regulation hepatic microenvironment various metabolisms, thereby mediating progression related liver diseases. For example, NRF2 FSP1, important regulatory proteins ferroptosis, development tumors failure. this manuscript, we present mechanisms concern with addition, summarize clinical advances targeted therapy for We expect manuscript can provide perspective treatment

Language: Английский

Citations

1
Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy DOI

Amr Ali Mohamed Abdelgawwad El-Sehrawy,

Teeba Ammar Rashid,

Muhammad Ikram Ullah

et al.

Functional & Integrative Genomics, Journal Year: 2025, Volume and Issue: 25(1)

Published: March 25, 2025

Language: Английский

Citations

0
Nuciferine activates intestinal TAS2R46 to attenuate metabolic disorders and hyperlipidemia via hepatic VLDL regulation DOI
Ding Chen,

Jian Ruan,

Jingxian Huang

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156800 - 156800

Published: April 1, 2025

Language: Английский

Citations

0